S100B and Alzheimer disease: When transgenic mice overexpressing S100B (TghuS100B mice) were crossed with the Tg2576 mouse model of AD, brain parenchymal and cerebral vascular β-amyloid (Aβ) deposits and Aβ levels were increased, accompanied by reactive astrocytosis and microgliosis and increased production of inflammatory cytokines [19].